Clinical Evaluation of Gokshuradi Kwath in Essential Hypertension
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Relief in Subjective Parameters:
研究概览
简要总结
This is an single arm open labelled clinical study to evaluate the effect of Gokshuradi Kwath in Essential Hypertension for the age group between 30 years to 60 years for duration of 30 days. It will be a clinical study of 30 patients freshly diagnosed with grade 1 Essential Hypertension as per JNC 8.Patient will be randomly selected irrespective of their gender, race, religion, occupation from the OPD/IPD of Quadra Institute of Ayurveda Roorkee Uttarakhand. The assessment of the trial will be done on the basis of Subjective and Objective parameters. Data depending upon above Subjective and Objective criteria and other variables will be collected and analysed statistically.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients willing for trial and who sign the consent form.
- •2.Patients in age group between 30-60 years.
- •3.Patients who are freshly diagnosed with stage-1 hypertension (i.e. Systolic Blood Pressure 140-159 mm of Hg and Diastolic Blood Pressure 90-99 mm of Hg according to JNC
- •4.Hypertension associated with/without disturbed lipid profile.
排除标准
- •1.Patients not willing for trial.
- •2.Patients less than 30 years and greater than 60 years of age.
- •3.Patient suffering from Stage 2 hypertension i.e. Systolic grater or equal to 160 mmHg and Diastolic grater or equal to 100 mmHg and isolated systolic Hypertension (i.e. Systolic Blood Pressure grater than 140 mmHg and Diastolic Blood Pressure less than 90 mmHg).
- •4.Patients suffering from secondary hypertension.
- •5.Patients taking any other Anti Hypertensive Drug.
- •6.Patient suffering from any other concommitent disease like Diabetes, Cardiovascular illness, Renal disease, Neurological illness and any other comorbidity.
- •7.Pregnant and lactating mothers will be excluded.
- •8.Patients who had participated in any clinical study/trial in past 6 months.
- •9.Any other condition which the principal investigator thought may jeopardize the study.
结局指标
主要结局
Relief in Subjective Parameters:
时间窗: Assesment will be done on 0 day (before treatment), and on 15th and 30th day (after the initiation of trial).
1.Shiroruja
时间窗: Assesment will be done on 0 day (before treatment), and on 15th and 30th day (after the initiation of trial).
2.Bhrama
时间窗: Assesment will be done on 0 day (before treatment), and on 15th and 30th day (after the initiation of trial).
3.Hridadrava
时间窗: Assesment will be done on 0 day (before treatment), and on 15th and 30th day (after the initiation of trial).
4.Swasa Kricchrita
时间窗: Assesment will be done on 0 day (before treatment), and on 15th and 30th day (after the initiation of trial).
次要结局
- Relief in Objective Criteria:(1.Systolic and Diastolic Blood Pressure.)
研究者
Nidhi
Quadra Institute of Ayurveda and Hospital Roorkee Haridwar